Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma

Experimental and Therapeutic Medicine

Volumn 4, Issue 2, 2012, Pages 311-316

  Hwang, Ilseon ^a   Kang, Yu Na ^a   Kim, Jin Young ^a   Do, Young Rok ^a   Song, Hong Suk ^a   Park, Keon Uk ^a  

^a Keimyung University   (South Korea)

Author keywords

Gastric cancer; Mucin 4; Prognosis

Indexed keywords

FORMALDEHYDE; MONOCLONAL ANTIBODY; MUCIN 1; MUCIN 4; PARAFFIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; TISSUE MICROARRAY;

EID: 84862637263     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.598     Document Type: Article

References (33)

1. Li XH, Zheng HC, Wang ZG, et al: The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays. Anticancer Res 28: 1061-1067, 2008.
2. Hollingsworth MA and Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60, 2004.
3. Zheng H, Takahashi H, Nakajima T, et al: MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132: 817-823, 2006.
4. Cozzi PJ, Wang J, Delprado W, et al: MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clin Exp Metastasis 22: 565-573, 2005.
5. Fattorossi A, Battaglia A, Malinconico P, et al: Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells. Exp Cell Res 280: 107-118, 2002.
6. Pandey P, Kharbanda S and Kufe D: Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res 55: 4000-4003, 1995.
7. Monges GM, Mathoulin-Portier MP, Acres RB, et al: Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples. Am J Clin Pathol 112: 635-640, 1999.
8. Nakamori S, Ota DM, Cleary KR, Shirotani K and Irimura T: MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106: 353-361, 1994.
9. Khodarev NN, Pitroda SP, Beckett MA, et al: MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer. Cancer Res 69: 2833-2837, 2009.
10. Moniaux N, Escande F, Porchet N, Aubert JP and Batra SK: Structural organization and classification of the human mucin genes. Front Biosci 6: D1192-D1206, 2001.
11. Ho SB, Niehans GA, Lyftogt C, et al: Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 53: 641-651, 1993.
12. Jeon JM, Lee HW, Park JY, et al: Expression of MUC1 and MUC4 and its prognostic significance in non-small cell lung carcinoma. Korean J Pathol 44: 397-403, 2010.
13. Shibahara H, Tamada S, Higashi M, et al: MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 39: 220-229, 2004.
14. Tamada S, Shibahara H, Higashi M, et al: MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res 12: 4257-4264, 2006.
15. Saitou M, Goto M, Horinouchi M, et al: MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol 58: 845-852, 2005.
16. Tsutsumida H, Goto M, Kitajima S, et al: MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer 55: 195-203, 2007.
17. Singh AP, Chauhan SC, Bafna S, et al: Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate 66: 421-429, 2006.
18. Kwon KY, Ro JY, Singhal N, et al: MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival. Arch Pathol Lab Med 131: 593-598, 2007.
19. Weed DT, Gomez-Fernandez C, Pacheco J, et al: MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma. Head Neck 26: 353-364, 2004.
20. Alos L, Lujan B, Castillo M, et al: Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 29: 806-813, 2005.
21. Weed DT, Gomez-Fernandez C, Yasin M, et al: MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes. Laryngoscope 114: 1-32, 2004.
22. Yonezawa S, Goto M, Yamada N, Higashi M and Nomoto M: Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 8: 3329-3341, 2008.
23. Akyurek N, Akyol G, Dursun A, Yamac D and Gunel N: Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract 198: 665-674, 2002.
24. Utsunomiya T, Yonezawa S, Sakamoto H, et al: Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res 4: 2605-2614, 1998.
25. Westgaard A, Schjolberg AR, Cvancarova M, Eide TJ, Clausen OP and Gladhaug IP: Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology 54: 337-347, 2009.
26. Shanmugam C, Jhala NC, Katkoori VR, et al: Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer 116: 3577-3586, 2010.
27. Lopez-Ferrer A, de Bolos C, Barranco C, et al: Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium. Gut 47: 349-356, 2000.
28. Buisine MP, Devisme L, Maunoury V, et al: Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. I. Stomach. A relationship to gastric carcinoma. J Histochem Cytochem 48: 1657-1666, 2000.
29. Senapati S, Chaturvedi P, Sharma P, et al: Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Br J Cancer 99: 949-956, 2008.
30. Moniaux N, Nollet S, Porchet N, Degand P, Laine A and Aubert JP: Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J 338: 325-333, 1999.
31. Carraway KL III, Rossi EA, Komatsu M, et al: An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J Biol Chem 274: 5263-5266, 1999.
32. Carraway KL, Ramsauer VP, Haq B and Carothers Carraway CA: Cell signaling through membrane mucins. Bioessays 25: 66-71, 2003.
33. Jepson S, Komatsu M, Haq B, et al: Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 21: 7524-7532, 2002.